I don't believe any small biotech company has been granted accelerated approval by Pazdur w/o a confirmatory trial started. One can argue this is more due to problems with the initial application, but it's a coincidence.
Both Allos's Folotyn and Gloucester's Istodax got accelerated approval without confirmatory trials started.